Abstract:Backgroud and objectives: The implementation of patient-specific quality assurance (PSQA) has become a crucial aspect of the radiation therapy process. Machine learning models have demonstrated their potential as virtual QA tools, accurately predicting the gamma passing rate (GPR) of volumetric modulated arc therapy (VMAT)plans, thereby ensuring safe and efficient treatment for patients. However, there is limited multi-center research dedicated to predicting the GPR. In this study, a dosiomics-based machine learning approach was employed to construct a prediction model for classifying GPR in multiple radiotherapy institutions. Additionally, the model's performance was compared by evaluating the impact of two distinct feature selection methods. Methods: A retrospective data collection was conducted on 572 VMAT patients across three radiotherapy institutions. Utilizing a three-dimensional dose verification technique grounded in real-time measurements, γ analysis was conducted according to the criteria of 3%/2 mm and 2%/2 mm, employing a dose threshold of 10% along with absolute dose and global normalization mode. Dosiomics features were extracted from the dose files, and distinct subsets of features were selected as inputs for the model using the random forest (RF) and RF combined with SHapley Additive exPlanations (SHAP) methods. The data underwent training using the extreme gradient boosting (XGBoost) algorithm, and the model's classification performance was assessed through F1-score and area under the curve (AUC) values. Results: The model exhibited optimal performance under the 3%/2 mm criteria, utilizing a subset of 20 features and attaining an AUC value of 0.88 and an F1-score of 0.89. Similarly, under the 2%/2 mm criteria, the model demonstrated superior performance with a subset of 10 features, resulting in an AUC value of 0.91 and an F1-score of 0.89. The feature selection methods of RF and RF + SHAP have achieved good model performance by selecting as few features as possible. Conclusion: Based on the multi-center PSQA results, it is possible to utilize dosiomics features extracted from dose files to construct a machine learning predictive model. This model demonstrates excellent discriminative abilities, thus promoting the progress of gamma passing rate prognostic models in clinical application and implementation. Furthermore, it holds potential in providing patients with secure and efficient personalized QA management, while also reducing the workload of medical physicists.

Integrating plan complexity and dosiomics features with deep learning in patient-specific quality assurance for volumetric modulated arc therapy

Deep learning for patient-specific quality assurance of volumetric modulated arc therapy: Prediction accuracy and cost-sensitive classification performance

Predicting the PSQA results of volumetric modulated arc therapy based on dosiomics features: a multi-center study

Pretreatment Patient-Specific Quality Assurance Prediction Based on 1D Complexity Metrics and 3D Planning Dose: Classification, Gamma Passing Rates, and DVH Metrics.

Machine learning and lean six sigma for targeted patient-specific quality assurance of volumetric modulated arc therapy plans

Predicting VMAT patient-specific QA results using a support vector classifier trained on treatment plan characteristics and linac QC metrics

Machine Learning for Patient-Specific Quality Assurance of VMAT: Prediction and Classification Accuracy.

Treatment plan complexity quantification for predicting gamma passing rates in patient‐specific quality assurance for stereotactic volumetric modulated arc therapy

Invertible and Variable Augmented Network for Pretreatment Patient-Specific Quality Assurance Dose Prediction

Patient-specific dosimetric endpoints based treatment plan quality control in radiotherapy

Machine learning and deep learning prediction of patient specific quality assurance in breast IMRT radiotherapy plans using Halcyon specific complexity indices

A StarGAN and transformer-based hybrid classification-regression model for multi-institution VMAT patient-specific quality assurance

Deep learning–based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers

Deep Learning for Patient-Specific Quality Assurance: Predicting Gamma Passing Rates for IMRT Based on Delivery Fluence Informed by Log Files.

Clinical implementation and evaluation of deep learning-assisted automatic radiotherapy treatment planning for lung cancer

A StarGAN and transformer‐based hybrid classification‐regression model for multi‐institution VMAT patient‐specific quality assurance

A Comparative Study of Deep Learning Dose Prediction Models for Cervical Cancer Volumetric Modulated Arc Therapy

The Potential Ability of Plan Complexity Metrics on the Dose Calculation and Plans Delivery in Intensity Modulated Radiotherapy

Implementation of volumetric-modulated arc therapy for locally advanced breast cancer patients: Dosimetric comparison with deliverability consideration of planning techniques and predictions of patient-specific QA results via supervised machine learning

Improvement of deep learning prediction model in patient‐specific QA for VMAT with MLC leaf position map and patient's dose distribution

Multi-omics deep learning for radiation pneumonitis prediction in lung cancer patients underwent volumetric modulated arc therapy